Drug resistance in malaria--a perspective.
D000328:Adult; D000349:Africa; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D001210:Asia, Southeastern; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007109:Immunity; D007300:Insect Control; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009154:Mutation; D010963:Plasmodium falciparum / Q000187:drug effects; D010965:Plasmodium malariae / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013020:South America
D000962:Antimalarials; D002738:Chloroquine; D002727:Proguanil; D011739:Pyrimethamine